WITHDRAWN: Experience with ustekinumab in patients with psoriasis enrolled in a large, multicenter, prospective, disease-based registry (Psoriasis Longitudinal Assessment and Registry [PSOLAR]) - 10/01/15
Doi : 10.1016/j.jaad.2014.10.025
Kim Papp, MD a, Alice B. Gottlieb, MD, PhD b, Luigi Naldi, MD c, David Pariser, MD d, Vincent Ho, MD e, Kavitha Goyal, MD f, Steven Fakharzadeh, MD, PhD f, Marc Chevrier, MD, PhD f, Stephen Calabro, MS f, Wayne Langholff, PhD g, Gerald Krueger, MD h
a Probity Medical Research, Waterloo, Ontario, Canada
b Tufts Medical Center, Boston, Massachusetts
c Centro Studi Gruppo Italiano Studi Epidemiologici in Dermatologia (GISED), Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy
d Eastern Virginia Medical School and Virginia Clinical Research Inc, Norfolk, Virginia
e University of British Columbia, Vancouver, British Columbia, Canada
f Janssen Scientific Affairs LLC, Horsham, Pennsylvania
g Janssen Research and Development LLC, Horsham, Pennsylvania
h University of Utah Health Sciences Center, Salt Lake City, Utah
Sous presse. Épreuves corrigées par l'auteur.
Disponible en ligne depuis le Saturday 10 January 2015
Abstract |
The above-referenced article has been voluntarily withdrawn by the authors in order to present more updated data in a subsequent manuscript.
The full Elsevier Policy on Article Withdrawal can be found at withdrawalpolicy.
Le texte complet de cet article est disponible en PDF.© 2014
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?